Early Outcomes of Thermal Ablation for Low-Risk Papillary Thyroid Cancer: A Multicenter Study from Latin American Interventional Thyroidology Association (LAITA)
- 6 August 2026
- journal article
- Published by SAGE Publications in Thyroid®
- Vol. 36 (10) , 1053-1062
Abstract
Background: Thermal ablation has emerged as a minimally invasive alternative for low-risk papillary thyroid cancer (PTC). However, data from Latin America remain scarce. This multicenter study evaluated the early efficacy and safety of thermal ablation for low-risk PTC across multiple Latin American centers. Methods: Retrospective cohort study including 251 patients with 252 tumors (T1N0M0 PTC, ≤2 cm) treated with ultrasound-guided radiofrequency ablation (RFA) at 12 centers across 6 Latin American countries from January 2019 to June 2025. Primary outcomes were complete tumor disappearance, disease progression, and complications. Results: Median age was 45.5 years (interquartile range [IQR]: 36.5–56), with 74.2% female patients. Median tumor size was 6.7 mm (IQR: 5–8); 92.1% were T1a (≤10 mm). After a median follow-up of 18 months (IQR 12–24, range 12–72), complete tumor disappearance was achieved in 89.7% overall (226/252), reaching 97.0% in tumors with ≥18 months and 100% with ≥36 months of follow-up. Tumor persistence was observed in 10.3% (26/252) at last follow-up, with no lymph node or distant metastases. The overall complication rate was 2.4% (6/252), all consisting of transient dysphonia. On multivariable analysis, tumor size >10 mm was independently associated with a lower likelihood of complete tumor disappearance (adjusted odds ratios [OR] 0.23 [CI: 0.07–0.78]), whereas follow-up >12 months was associated with a higher likelihood (adjusted OR: 11.33 [CI: 3.61–35.6]). A supplementary post hoc analysis suggested a possible association between higher general operator volume (≥250 RFA procedures) and complete disappearance. Conclusions: RFA demonstrates excellent efficacy and acceptable safety for T1a low-risk PTC in Latin American patients, with outcomes comparable with other series, supporting it as a viable alternative to surgery or active surveillance in selected patients. Efficacy for T1b tumors was lower and based on a small number of cases; ablation of T1b disease should therefore be regarded as requiring further investigation, ideally within the framework of a clinical trial.Keywords
This publication has 37 references indexed in Scilit:
- Thermal Ablation for Low-risk Papillary Thyroid Carcinoma: Comparing Outcomes in T1N0M0 and T2N0M0 PTCAcademic Radiology, 2025
- Risk Factors for Disease Progression in Thermal Ablation of Papillary Thyroid Cancer—A Large-sample AnalysisAcademic Radiology, 2025
- Management of low-risk papillary thyroid cancer. Minimally-invasive treatments dictate a further paradigm shift?Endocrine, 2024
- Thermal ablation for multifocal papillary thyroid microcarcinoma: a systematic review and meta-analysisEndocrine, 2024
- Efficacy and safety of thermal ablation modalities for the treatment of papillary thyroid microcarcinoma: Systematic Review and network meta-analysisHeliyon, 2024
- Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies AssociationHead & Neck, 2021
- Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas: systematic review and meta-analysisEuropean Radiology, 2021
- Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical TreatmentJAMA Otolaryngology–Head & Neck Surgery, 2019
- Current Thyroid Cancer Trends in the United StatesJAMA Otolaryngology–Head & Neck Surgery, 2014
- Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated PatientsWorld Journal of Surgery, 2002